|
Want
more "standardization" of semen analysis results?
by Leo Vankrieken, Eur. Eng.
International Marketing Manager
Reproductive Endocrinology
Microscopic
semen analysis is a time-consuming and arduous task for even the most
skilled technologist. Automated systems have made the analytical component
faster, less labor intensive and more objective. Of the current technologiesprimarily
semen quality analyzers using electro-optics, and computer-assisted semen
analysiselectro-optics is proving more user friendly and cost effective
for routine screening of semen quality in the assessment of male infertility.
Semen
analysis is a critical element in the investigation of male infertility,
along with hormonal testing, medical history and a physical examination
to rule out any sexual or ejaculatory dysfunction. Although the occurrence
of infertility in men has often been underestimated, just as many cases
involve a clinical problem with the male as with the female (Table 1).
Table 1. Breakdown
of clinically diagnosed infertility cases by gender.1
| Male
only |
35%
|
| Female
only |
35%
|
| Both
male and female |
25%
|
| Undetermined
cause |
5%
|
Diagnosing male
infertility
Semen analysis is used to determine whether spermatozoa quality is adequate
to fertilize an oocyte. The following terms have been adopted to describe
male fertility/infertility status:
 |
Normozoospermia:
normal ejaculate |
 |
Oligozoospermia:
sperm concentration less than the reference value |
 |
Asthenozoospermia:
motility value less than the reference value |
 |
Teratozoospermia:
percentage of spermatozoa with normal morphology less than standard
value |
 |
Oligoasthenoteratozoospermia:
disturbance of all three variables sperm concentration, motility and
morphology |
 |
Azoospermia:
no spermatozoa in the ejaculate, occurring in approximately 10 to
20 percent of men receiving care in infertility centers |
 |
Aspermia:
no ejaculate. |
In certain irreversible
cases, in vitro fertilization (IVF) and related technologies, such as
intracytoplasmic sperm injection (ICSI), can still make it possible for
some men to father biological children. Adjunctive hormone, enzyme, nutritional
and chromosomal testing, along with visual and functional assessments,
can assist in determining the cause and appropriate therapeutic interventions.
Various
technologies
Microscopic analysis has been the primary method of evaluating semen since
the 1920s. It provides a sperm count and classifies motility and morphology.
This method has several drawbacks: it is tedious, labor intensive, has
poor reproducibility and is highly subjective, the accuracy of results
being dependent on several factors including the expertise of the technologist.
Although computer-assisted
semen analysis (CASA) systems were introduced into the market in the 1980s,
they are found mainly in universities, research laboratories and sophisticated
IVF centers. CASA systems primarily report motility and provide a more
detailed classification and analysis once a determination of infertility
has been established. The cost, labor-intensive sample processing, skill
required for operation and limited menu have restricted the adoption of
CASA systems for routine semen analysis.
In the 1990s, Medical
Electronic Systems Ltd. (MES; Caesarea, Israel) introduced the first line
of automated semen analyzers for routine screening of male infertility.
The latest model, the SQA-V, distributed by DPC under the brand name SPERMALITETM,
provides a basic screening analysis of concentration, motility and morphology
in 75 seconds. This automated system uses electro-optics to transmit light
through the specimen to the photodetectors that measure the patterns of
light emitted. Variations in the light beams are detected, digitized and
routed to an internal computer. The computer analyzes the data through
the application of specially derived algorithms, and results are reported
in a form that complies with WHO and Kruger* criteria.
Also available with
the SPERMALITE system is the V-Sperm video-enhanced visualization
software, which allows for enhanced direct visualization (1000 x magnification)
of samples contained either in the self-aspirating capillary or in conventional
microscope slides. The visualization system serves as a complementary
tool to view atypical cases, identify specific pathologies, and enable
more detailed manual sperm morphology assessment when required. With the
aid of an external video card, video clips (MPEG files) and images may
be stored on an external PC and added to patient reports. The enhanced
data management, data analysis, graphs and image processing provide operators
expanded system operation.
The SPERMALITE
provides routine laboratories with a quick, reproducible and accurate
means of evaluating semen samples, without painstaking manual analysis.
It also requires minimal skill to operate and virtually no sample preparation.
The addition of the SPERMALITE to DPC's line of reproductive products
is just another demonstration of the Company's commitment to provide its
customers with more comprehensive solutions for all their testing needs.
 |
The SPERMALITE SQA-V provides laboratories with a quick, reproducible
and accurate means of screening semen samples. |
*Available outside
the US
Common
Semen Analysis Parameters
A
basic semen analysis evaluates the number of spermatozoa (per volume and
per ejaculate), motility and morphology.
Concentration
is the number of sperm per milliliter of seminal fluid; the sperm count
is the total number of sperm per ejaculate, calculated as the product
of sperm concentration and ejaculate volume.1 Average sperm concentration
is normally more than 60 million per milliliter, while a concentration
of less than 20 million per milliliter is considered subfertile.
Motility is
the ratio of the number of moving sperm to the total number of sperm (in
a given volume), expressed as a percentage. Sperm motility is assessed
by categorization into any of four groups:
Rapid progressive:
a
Slow progressive: b
Nonprogressive: c
Immotile: d.
There should be more
than 40 million sperm in the ejaculate. The World Health Organization
(WHO) reference values state that 50% or more of the sperm should be motile
(grades a + b + c) or 25% or more should exhibit progressive motility
(grade a + b).2
Morphology
refers to the shape and appearance of spermatozoa, taking into account
whether or not the sperm head, neck, midpiece and tail are free of defects.
During analysis, sperm are characterized according to specific sets of
criteria, the most common being the WHO and Kruger morphology standards.
The WHO has not established a reference value for the percentage of sperm
that should be free of morphological defects, but data suggest that the
fertilization rate in vitro decreases as normal morphology falls below
15 percent.1
Other common parameters
evaluated in a semen analysis include volume, pH, white blood cell count,
presence of antisperm antibodies, color, viscosity, agglutination, aggregation
and time until liquefaction.
References
1. Jeyendran RS. Interpretation of semen analysis results: a practical
guide. Cambridge, UK: Cambridge University Press, 2000.
2. World Health Organization.
WHO laboratory manual for the examination of human semen and sperm-cervical
mucus interaction. 4th ed. Cambridge, UK: Cambridge University Press,
2000.
|